Cytiva delivers modular biologics factory to Lonza

• From site selection in Guangzhou Biopark to handover during the global pandemic, 17,000-square meter site was completed in less than two years
• From Lonza’s first manufacturing site for biologics in China, the healthcare leader will provide services and manufacturing needed to respond to growing global pharmaceutical needs
• Site to become a strategic base in China for Lonza to provide CDMO services throughout Asia Pacific region

свернуть